155 related articles for article (PubMed ID: 20574151)
1. miRNA-520b and miR-520e sensitize breast cancer cells to complement attack via directly targeting 3'UTR of CD46.
Cui W; Zhang Y; Hu N; Shan C; Zhang S; Zhang W; Zhang X; Ye L
Cancer Biol Ther; 2010 Aug; 10(3):232-41. PubMed ID: 20574151
[TBL] [Abstract][Full Text] [Related]
2. miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8.
Hu N; Zhang J; Cui W; Kong G; Zhang S; Yue L; Bai X; Zhang Z; Zhang W; Zhang X; Ye L
J Biol Chem; 2011 Apr; 286(15):13714-22. PubMed ID: 21343296
[TBL] [Abstract][Full Text] [Related]
3. LncRNA ZFAS1 contributes to osteosarcoma progression via miR-520b and miR-520e-mediated inhibition of RHOC signaling.
Liu X; Wang M; Zhang L; Huang L
Clinics (Sao Paulo); 2023; 78():100143. PubMed ID: 36473367
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).
Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X
Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365
[TBL] [Abstract][Full Text] [Related]
5. Capn4 expression is modulated by microRNA-520b and exerts an oncogenic role in prostate cancer cells by promoting Wnt/β-catenin signaling.
Ren W; Wang D; Li C; Shu T; Zhang W; Fu X
Biomed Pharmacother; 2018 Dec; 108():467-475. PubMed ID: 30241050
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of CD55 and CD46 expression by anti-sense phosphorothioate oligonucleotides (S-ODNs) sensitizes tumour cells to complement attack.
Zell S; Geis N; Rutz R; Schultz S; Giese T; Kirschfink M
Clin Exp Immunol; 2007 Dec; 150(3):576-84. PubMed ID: 17903221
[TBL] [Abstract][Full Text] [Related]
7. The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.
Zheng L; Li X; Gu Y; Lv X; Xi T
Breast Cancer Res Treat; 2015 Feb; 150(1):105-18. PubMed ID: 25701119
[TBL] [Abstract][Full Text] [Related]
8. MiR-520b suppresses proliferation of hepatoma cells through targeting ten-eleven translocation 1 (TET1) mRNA.
Zhang W; Lu Z; Gao Y; Ye L; Song T; Zhang X
Biochem Biophys Res Commun; 2015 May; 460(3):793-8. PubMed ID: 25824049
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Complement-Dependent Cytotoxicity by MicroRNAs miR-200b, miR-200c, and miR-217.
Hillman Y; Mazkereth N; Farberov L; Shomron N; Fishelson Z
J Immunol; 2016 Jun; 196(12):5156-65. PubMed ID: 27183614
[TBL] [Abstract][Full Text] [Related]
10. XIAP 3'-untranslated region as a ceRNA promotes FSCN1 function in inducing the progression of breast cancer by binding endogenous miR-29a-5p.
Wu Q; Yan H; Tao SQ; Wang XN; Mou L; Chen P; Cheng XW; Wu WY; Wu ZS
Oncotarget; 2017 Mar; 8(10):16784-16800. PubMed ID: 28186968
[TBL] [Abstract][Full Text] [Related]
11. miR-520b Inhibits IGF-1R to Increase Doxorubicin Sensitivity and Promote Cell Apoptosis in Breast Cancer.
Zhang H; Zheng XD; Zeng XH; Li L; Zhou Q
Yakugaku Zasshi; 2021 Mar; 141(3):415-426. PubMed ID: 33116033
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic p95HER2 regulates Na+-HCO3- cotransporter NBCn1 mRNA stability in breast cancer cells via 3'UTR-dependent processes.
Gorbatenko A; Olesen CW; Loebl N; Sigurdsson HH; Bianchi C; Pedraz-Cuesta E; Christiansen J; Pedersen SF
Biochem J; 2016 Nov; 473(21):4027-4044. PubMed ID: 27609814
[TBL] [Abstract][Full Text] [Related]
13. ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer.
Duhachek-Muggy S; Zolkiewska A
BMC Cancer; 2015 Mar; 15():93. PubMed ID: 25886595
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-520e suppresses non-small-cell lung cancer cell growth by targeting Zbtb7a-mediated Wnt signaling pathway.
Zhijun Z; Jingkang H
Biochem Biophys Res Commun; 2017 Apr; 486(1):49-56. PubMed ID: 28242196
[TBL] [Abstract][Full Text] [Related]
15. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
[TBL] [Abstract][Full Text] [Related]
16. MiR-520b restrains cell growth by targeting HDAC4 in lung cancer.
Jin K; Zhao W; Xie X; Pan Y; Wang K; Zhang H
Thorac Cancer; 2018 Oct; 9(10):1249-1254. PubMed ID: 30106218
[TBL] [Abstract][Full Text] [Related]
17. MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2).
Ma MT; He M; Wang Y; Jiao XY; Zhao L; Bai XF; Yu ZJ; Wu HZ; Sun ML; Song ZG; Wei MJ
Cancer Lett; 2013 Oct; 339(1):107-15. PubMed ID: 23879965
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-146a inhibits cell migration and invasion by targeting RhoA in breast cancer.
Liu Q; Wang W; Yang X; Zhao D; Li F; Wang H
Oncol Rep; 2016 Jul; 36(1):189-96. PubMed ID: 27175941
[TBL] [Abstract][Full Text] [Related]
19. Posttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer.
Li X; Xu Y; Ding Y; Li C; Zhao H; Wang J; Meng S
Mol Cancer; 2018 Aug; 17(1):113. PubMed ID: 30068375
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-520e restricts the proliferation and invasion of glioma cells through the downregulation of Wnt/β-catenin signaling by targeting fibroblast growth factor 19.
Zhang L; Cao Y; Jia D; Wei M
Biochem Biophys Res Commun; 2019 Apr; 511(3):619-625. PubMed ID: 30826062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
